AssetMark Inc’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-240
Closed -$3.82K 3383
2025
Q3
$3.82K Sell
240
-96
-29% -$1.58K ﹤0.01% 2430
2025
Q2
$5.95K Sell
336
-261
-44% -$5.08K ﹤0.01% 2087
2025
Q1
$12.4K Sell
597
-202,726
-100% -$3.84M ﹤0.01% 1806
2024
Q4
$3.76M Sell
203,323
-12,377
-6% -$238K 0.01% 561
2024
Q3
$4.23M Buy
215,700
+106,342
+97% +$2.12M 0.01% 482
2024
Q2
$2.15M Sell
109,358
-18,674
-15% -$354K 0.01% 596
2024
Q1
$2.31M Sell
128,032
-7,836
-6% -$142K 0.01% 552
2023
Q4
$2.3M Buy
135,868
+7,121
+6% +$142K 0.01% 510
2023
Q3
$2.56M Buy
+128,747
New +$2.44M 0.01% 464

Other funds holding BTAL

AssetMark Inc's BTAL Position: Q4 2025 in Review

AssetMark Inc sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q4 2025, closing a stake of 240 shares — an estimated $3.82K sold.

AssetMark Inc first reported a position in BTAL in Q3 2023 and held it in 9 quarters. The position peaked at $4.23M in Q3 2024. 81 funds tracked by Wall St. Rank hold BTAL as of Q4 2025.

  • AssetMark Inc reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q4 2025 after selling out during the quarter.
  • AssetMark Inc sold 240 AGF US Market Neutral Anti-Beta Fund shares in Q4 2025, an estimated $3.82K.
  • AssetMark Inc first reported a position in AGF US Market Neutral Anti-Beta Fund in Q3 2023 and held it in 9 quarters.
  • AssetMark Inc's AGF US Market Neutral Anti-Beta Fund position peaked at $4.23M in Q3 2024.
  • 81 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q4 2025.

Based on AssetMark Inc's 13F filing for Q4 2025, filed 23 Jan 2026.